Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1035 dni temu
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 779 dni temu
Malaysia Stock Market May Spin Its Wheels On Thursday

Malaysia Stock Market May Spin Its Wheels On Thursday

The Malaysia stock market has finished lower in back-to-back sessions, slipping almost 7 points or 0.4 percent in that span. The Kuala Lumpur Composite Index now sits just above the 1,610-point plateau and it may remain stuck in neutral on Thursday.
RTTNews | 3 minut temu
Japan Bourse May See Mild Downside Correction

Japan Bourse May See Mild Downside Correction

The Japan stock market rebounded on Wednesday, one day after ending the two-day winning streak in which it had rallied more than 1,800 points or 3 percent. The Nikkei 225 now rests just above the 51,300-point plateau although it may run out of steam on Thursday.
RTTNews | 18 minut temu
South Korea Shares May Be Stuck In Neutral

South Korea Shares May Be Stuck In Neutral

The South Korea stock market bounced higher again on Wednesday, one day after halting the two-day winning streak in which it had gained almost 200 points or 5 percent. Now at a fresh record closing high, the KOSPI sits just above the 4,080-point plateau although investors may lock in gains on Thursday.
RTTNews | 33 minut temu
Japan Rate Decision On Tap For Thursday

Japan Rate Decision On Tap For Thursday

The Bank of Japan will wrap up its monetary policy meeting on Thursday and then announce its decision on interest rates, highlighting a modest day for Asia-Pacific economic activity. The BoJ is expected to keep its benchmark lending rate steady at 0.50 percent.
RTTNews | 1g 33 minut temu
Swiss Market Ends On Weak Note

Swiss Market Ends On Weak Note

After spending a few minutes in positive territory at the start, Switzerland stock market's benchmark SMI drifted down and then stayed weak right through the trading session on Wednesday, with investors digesting corporate earnings updates and looking ahead to the Federal Reserve's rate decision due later in the day.
RTTNews | 4g 50 minut temu